Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP211350.RAfyllAGlOlxBFjGrh-l0XYmlCZvSqxHImveMo9V3rfXk#assertion> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[Although the first Moss study reported a significant improvement in respiratory function (FEV(1)) 30 days after participants had received their first dose of gene therapy agent, this finding was not confirmed in their larger second study or in our meta-analysis.In participants who received the CFTR gene transfer agents in the Alton study, 'influenza-like' symptoms were found (relative risk 7.00 (95% confidence interval (CI) 1.10 to 44.61)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion evidence source_evidence_literature provenance.
- assertion SIO_000772 17443603 provenance.
- assertion wasDerivedFrom BEFREE provenance.
- assertion wasGeneratedBy ECO_0000203 provenance.